Market research
ADR.AU Adherium Limited
AU AUD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 0.8855
- Dividend yield
- Not available
- Beta
- 1.04
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- AU000000ADR1
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 0.8855
- Dividend yield
- Not available
- Beta
- 1.04
About
About Adherium Limited
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution. The company was founded in 2001 and is based in Melbourne, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ADR.AU discussion.
5 years, 6 months ago
Adherium Limited is currently in a long term downtrend where the price is trading 21.1% below its 200 day moving average.
From a valuation standpoint, the stock is 96.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.5.
Adherium Limited's total revenue sank by 82.2% to $253K since the same quarter in the previous year.
Its net income has dropped by 91.5% to $-9M since the same quarter in the previous year.
Finally, its free cash flow fell by 75.7% to $-3M since the same quarter in the previous year.
Based on the above factors, Adherium Limited gets an overall score of 1/5.